Form D · Pharmaceuticals
TearClear Corp.
Princeton, NJ · CIK 0001706975
Offering snapshot reported Jul 13, 2023 · SEC filing
- Reported sold
- $11.8M Offering amount: $16M
- Investors reported
- 70 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 29, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2023 | Initial | $11,764,262 | No comparison | 70 | SEC filing |
| Aug 16, 2022 | Amendment | $5,900,000 | $900,000vs Apr 27, 2022 | 43 | SEC filing |
| Apr 27, 2022 | Initial | $5,000,000 | No comparison | 40 | SEC filing |
| Aug 19, 2020 | Amendment | $22,346,503 | $99,999vs Jul 23, 2020 | 51 | SEC filing |
| Jul 23, 2020 | Amendment | $22,246,504 | $6,466,826vs Apr 28, 2020 | 50 | SEC filing |
| Apr 28, 2020 | Initial | $15,779,678 | No comparison | 39 | SEC filing |
| Feb 14, 2020 | Initial | $2,790,000 | No comparison | 32 | SEC filing |
| Feb 14, 2019 | Initial | $4,999,999 | No comparison | 22 | SEC filing |
| May 31, 2017 | Amendment | $4,631,149 | $2,245,000vs May 19, 2017 | 11 | SEC filing |
| May 19, 2017 | Initial | $2,386,149 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-486781
Total amount sold includes (i) New Cash $1,302,513.28; an (ii) $10,461,748.44 of converted notes.
Source: Form D, filed Jul 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Bailey | Director |
| Robert Dempsey | Director, Executive |
| Richard Harrison | Executive |
| Richard Heinick | Director |
| Kevin Hershfield | Executive |
| William Link | Director |
| Steve Pazol | Director |
| Stuart Raetzman | Director |
| Tyler Stowater | Director |
| Srini Venkatesh | Executive |
| Jeffry Weinhuff | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3495 Us Hwy 1, 34 Ste1164
Princeton, NJ, 08540
Princeton, NJ, 08540